NCT07014189View on ClinicalTrials.gov

Nevirapine / Lamivudine for HIV Maintenance Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

January 10, 2023

Study Completion Date

August 31, 2023

Conditions
HIV InfectionAntiretroviral TreatmentMaintenance Therapy
Interventions
DRUG

Neviparine (NVP)/ Lamivudine (3TC)

Treatment with nevirapine (400mg retard) and lamivudine (300mg) once daily

Trial Locations (1)

9007

Cantonal Hospital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Cantonal Hospital of St. Gallen

OTHER

NCT07014189 - Nevirapine / Lamivudine for HIV Maintenance Therapy | Biotech Hunter | Biotech Hunter